Pharmacological Parameters and Pharmacokinetic Variability Derived from Bioequivalence Trials in a Mexican Population
Clinical Pharmacology in Drug Development · 2024
DOI: 10.1002/cpdd.1343 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Pharmacology in Drug Development, 2024. Verfasst von Carlos Alejandro Díaz-Tufinio und 2 weiteren Autor:innen. Beteiligte Einrichtung: Axis Clinicals Latina, Mexico City, Mexico. Hauptthemen laut MEDLINE: Therapeutic Equivalency. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 23 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Axis Clinicals Latina, Mexico City, Mexico.
- Tecnologico de Monterrey, School of Engineering and Sciences, Mexico City, Mexico.
- Laboratorio de Farmacogenomica, Instituto Nacional de Medicina Genomica, Mexico City, Mexico.
Zitieren
APA
Díaz-Tufinio, C. A., Gonzalez-Covarrubias, V., & Palma-Aguirre, J. A. (2024). Pharmacological Parameters and Pharmacokinetic Variability Derived from Bioequivalence Trials in a Mexican Population. Clinical Pharmacology in Drug Development. https://doi.org/10.1002/cpdd.1343
Vancouver
Díaz-Tufinio CA, Gonzalez-Covarrubias V, Palma-Aguirre JA. Pharmacological Parameters and Pharmacokinetic Variability Derived from Bioequivalence Trials in a Mexican Population. Clinical Pharmacology in Drug Development. 2024. doi:10.1002/cpdd.1343
BibTeX
@article{DazTufinio2024,
author = {Díaz-Tufinio, Carlos Alejandro and Gonzalez-Covarrubias, Vanessa and Palma-Aguirre, José Antonio},
title = {Pharmacological Parameters and Pharmacokinetic Variability Derived from Bioequivalence Trials in a Mexican Population},
journal = {Clinical Pharmacology in Drug Development},
year = {2024},
doi = {10.1002/cpdd.1343}
}
EUVIMED